Education
About Us
Working with TipRanks
Follow Us
Aim Immunotech Inc. (AIM)
:AIM
Total Valuation
AIM ImmunoTech has a market cap or net worth of $2.91M. The enterprise value is ―.
Market Cap$2.91M
Enterprise Value―
Share Statistics
AIM ImmunoTech has 72,290,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding72,290,030
Owned by Insiders4.62%
Owned by Institutions0.19%
Financial Efficiency
AIM ImmunoTech’s return on equity (ROE) is -2.83 and return on invested capital (ROIC) is -291.42%.
Return on Equity (ROE)-2.83
Return on Assets (ROA)-1.49
Return on Invested Capital (ROIC)-291.42%
Return on Capital Employed (ROCE)-2.97
Revenue Per Employee9.62K
Profits Per Employee-1.38M
Employee Count21
Asset Turnover0.01
Inventory Turnover-0.14
Valuation Ratios
The current PE Ratio of AIM ImmunoTech is -0.74. AIM ImmunoTech’s PEG ratio is -0.02.
PE Ratio-0.74
PS Ratio47.61
PB Ratio2.50
Price to Fair Value2.09
Price to FCF-0.41
Price to Operating Cash Flow-0.35
PEG Ratio-0.02
Income Statement
In the last 12 months, AIM ImmunoTech had revenue of 202.00K and earned -28.96M in profits. Earnings per share was -0.60.
Revenue202.00K
Gross Profit160.00K
Operating Income-31.92M
Pretax Income-28.96M
Net Income-28.96M
EBITDA-31.68M
Earnings Per Share (EPS)-0.60
Cash Flow
In the last 12 months, operating cash flow was -20.69M and capital expenditures -635.00K, giving a free cash flow of -21.33M billion.
Operating Cash Flow-20.69M
Free Cash Flow-21.33M
Free Cash Flow per Share-0.30
Dividends & Yields
AIM ImmunoTech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.57
52-Week Price Change-91.11%
50-Day Moving Average0.12
200-Day Moving Average0.23
Relative Strength Index (RSI)26.88
Average Volume (3m)769.77K
Important Dates
AIM ImmunoTech upcoming earnings date is May 15, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateMay 15, 2025
Ex-Dividend Date―
Financial Position
AIM ImmunoTech as a current ratio of 1.68, with Debt / Equity ratio of 116.79%
Current Ratio1.68
Quick Ratio1.72
Debt to Market Cap0.00
Net Debt to EBITDA0.15
Interest Coverage Ratio0.00
Taxes
In the past 12 months, AIM ImmunoTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
AIM ImmunoTech EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.76.
EV to Sales82.43
EV to EBITDA-0.53
EV to Free Cash Flow-0.76
EV to Operating Cash Flow-0.78
Balance Sheet
AIM ImmunoTech has $7.20M in cash and marketable securities with $3.40M in debt, giving a net cash position of -$3.80M billion.
Cash & Marketable Securities$7.20M
Total Debt$3.40M
Net Cash-$3.80M
Net Cash Per Share-$0.05
Tangible Book Value Per Share$0.16
Margins
Gross margin is 20.00%, with operating margin of -15800.00%, and net profit margin of -14337.62%.
Gross Margin20.00%
Operating Margin-15800.00%
Pretax Margin-14337.62%
Net Profit Margin-14337.62%
EBITDA Margin-15682.18%
EBIT Margin-15800.00%
Analyst Forecast
The average price target for AIM ImmunoTech is $4.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$4.50
Price Target Upside11150.00% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast-15.84%
EPS Growth Forecast47.31%